The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Algal DHA and ARA Market Research Report 2025
Synopsis
Docosahexaenoic acid (DHA) is an omega-3 fatty acid that is a primary structural component of the human brain, cerebral cortex, skin, and retina. It can be synthesized from alpha-linolenic acid or obtained directly from maternal milk (breast milk), fish oil, or algae oil.
Arachidonic acid is a polyunsaturated fatty acid present in the phospholipids (especially phosphatidylethanolamine, phosphatidylcholine, and phosphatidylinositides) of membranes of the body's cells, and is abundant in the brain, muscles, and liver.
The global Algal DHA and ARA market was valued at US$ 632.9 million in 2023 and is anticipated to reach US$ 1578.6 million by 2030, witnessing a CAGR of 13.8% during the forecast period 2024-2030.
The global top five algal DHA and ARA manufacturers include DSM, CABIO, Lonza Group, Runke, Corbion, with a total market share of more than 75%, of which the largest producer is DSM, with a market share of more than 50%. Europe is the global most important algal DHA and ARA producing area, with a market share of more than 40%. In terms of type, DHA powder has a market share of over 35%. In the application field, the market share of infant formula is about 50%.
This report aims to provide a comprehensive presentation of the global market for Algal DHA and ARA, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Algal DHA and ARA.
Report Scope
The Algal DHA and ARA market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Algal DHA and ARA market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Algal DHA and ARA manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
DSM
Roquette
ADM
Corbion
Lonza Group
CABIO
AlgiSys
Fuxing
Runke
Cellana
JC Biotech
Yuexiang
FEMICO
Huison
Qingdao Keyuan
Yidie
Kingdomway
Shandong Yuexiang
Segment by Type
DHA Oil
DHA Powder
ARA Oil
ARA Powder
Segment by Application
Infant Formula
Nutritional Supplement
Food and Beverages
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Algal DHA and ARA manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Algal DHA and ARA in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Docosahexaenoic acid (DHA) is an omega-3 fatty acid that is a primary structural component of the human brain, cerebral cortex, skin, and retina. It can be synthesized from alpha-linolenic acid or obtained directly from maternal milk (breast milk), fish oil, or algae oil.
Arachidonic acid is a polyunsaturated fatty acid present in the phospholipids (especially phosphatidylethanolamine, phosphatidylcholine, and phosphatidylinositides) of membranes of the body's cells, and is abundant in the brain, muscles, and liver.
The global Algal DHA and ARA market was valued at US$ 632.9 million in 2023 and is anticipated to reach US$ 1578.6 million by 2030, witnessing a CAGR of 13.8% during the forecast period 2024-2030.
The global top five algal DHA and ARA manufacturers include DSM, CABIO, Lonza Group, Runke, Corbion, with a total market share of more than 75%, of which the largest producer is DSM, with a market share of more than 50%. Europe is the global most important algal DHA and ARA producing area, with a market share of more than 40%. In terms of type, DHA powder has a market share of over 35%. In the application field, the market share of infant formula is about 50%.
This report aims to provide a comprehensive presentation of the global market for Algal DHA and ARA, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Algal DHA and ARA.
Report Scope
The Algal DHA and ARA market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Algal DHA and ARA market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Algal DHA and ARA manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
DSM
Roquette
ADM
Corbion
Lonza Group
CABIO
AlgiSys
Fuxing
Runke
Cellana
JC Biotech
Yuexiang
FEMICO
Huison
Qingdao Keyuan
Yidie
Kingdomway
Shandong Yuexiang
Segment by Type
DHA Oil
DHA Powder
ARA Oil
ARA Powder
Segment by Application
Infant Formula
Nutritional Supplement
Food and Beverages
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Algal DHA and ARA manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Algal DHA and ARA in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Algal DHA and ARA Market Overview
1.1 Product Overview and Scope of Algal DHA and ARA
1.2 Algal DHA and ARA Segment by Type
1.2.1 Global Algal DHA and ARA Market Value Comparison by Type (2024-2030)
1.2.2 DHA Oil
1.2.3 DHA Powder
1.2.4 ARA Oil
1.2.5 ARA Powder
1.3 Algal DHA and ARA Segment by Application
1.3.1 Global Algal DHA and ARA Market Value by Application: (2024-2030)
1.3.2 Infant Formula
1.3.3 Nutritional Supplement
1.3.4 Food and Beverages
1.3.5 Others
1.4 Global Algal DHA and ARA Market Size Estimates and Forecasts
1.4.1 Global Algal DHA and ARA Revenue 2019-2030
1.4.2 Global Algal DHA and ARA Sales 2019-2030
1.4.3 Global Algal DHA and ARA Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Algal DHA and ARA Market Competition by Manufacturers
2.1 Global Algal DHA and ARA Sales Market Share by Manufacturers (2019-2024)
2.2 Global Algal DHA and ARA Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Algal DHA and ARA Average Price by Manufacturers (2019-2024)
2.4 Global Algal DHA and ARA Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Algal DHA and ARA, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Algal DHA and ARA, Product Type & Application
2.7 Algal DHA and ARA Market Competitive Situation and Trends
2.7.1 Algal DHA and ARA Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Algal DHA and ARA Players Market Share by Revenue
2.7.3 Global Algal DHA and ARA Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Algal DHA and ARA Retrospective Market Scenario by Region
3.1 Global Algal DHA and ARA Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Algal DHA and ARA Global Algal DHA and ARA Sales by Region: 2019-2030
3.2.1 Global Algal DHA and ARA Sales by Region: 2019-2024
3.2.2 Global Algal DHA and ARA Sales by Region: 2025-2030
3.3 Global Algal DHA and ARA Global Algal DHA and ARA Revenue by Region: 2019-2030
3.3.1 Global Algal DHA and ARA Revenue by Region: 2019-2024
3.3.2 Global Algal DHA and ARA Revenue by Region: 2025-2030
3.4 North America Algal DHA and ARA Market Facts & Figures by Country
3.4.1 North America Algal DHA and ARA Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Algal DHA and ARA Sales by Country (2019-2030)
3.4.3 North America Algal DHA and ARA Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Algal DHA and ARA Market Facts & Figures by Country
3.5.1 Europe Algal DHA and ARA Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Algal DHA and ARA Sales by Country (2019-2030)
3.5.3 Europe Algal DHA and ARA Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Algal DHA and ARA Market Facts & Figures by Country
3.6.1 Asia Pacific Algal DHA and ARA Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Algal DHA and ARA Sales by Country (2019-2030)
3.6.3 Asia Pacific Algal DHA and ARA Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Algal DHA and ARA Market Facts & Figures by Country
3.7.1 Latin America Algal DHA and ARA Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Algal DHA and ARA Sales by Country (2019-2030)
3.7.3 Latin America Algal DHA and ARA Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Algal DHA and ARA Market Facts & Figures by Country
3.8.1 Middle East and Africa Algal DHA and ARA Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Algal DHA and ARA Sales by Country (2019-2030)
3.8.3 Middle East and Africa Algal DHA and ARA Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Algal DHA and ARA Sales by Type (2019-2030)
4.1.1 Global Algal DHA and ARA Sales by Type (2019-2024)
4.1.2 Global Algal DHA and ARA Sales by Type (2025-2030)
4.1.3 Global Algal DHA and ARA Sales Market Share by Type (2019-2030)
4.2 Global Algal DHA and ARA Revenue by Type (2019-2030)
4.2.1 Global Algal DHA and ARA Revenue by Type (2019-2024)
4.2.2 Global Algal DHA and ARA Revenue by Type (2025-2030)
4.2.3 Global Algal DHA and ARA Revenue Market Share by Type (2019-2030)
4.3 Global Algal DHA and ARA Price by Type (2019-2030)
5 Segment by Application
5.1 Global Algal DHA and ARA Sales by Application (2019-2030)
5.1.1 Global Algal DHA and ARA Sales by Application (2019-2024)
5.1.2 Global Algal DHA and ARA Sales by Application (2025-2030)
5.1.3 Global Algal DHA and ARA Sales Market Share by Application (2019-2030)
5.2 Global Algal DHA and ARA Revenue by Application (2019-2030)
5.2.1 Global Algal DHA and ARA Revenue by Application (2019-2024)
5.2.2 Global Algal DHA and ARA Revenue by Application (2025-2030)
5.2.3 Global Algal DHA and ARA Revenue Market Share by Application (2019-2030)
5.3 Global Algal DHA and ARA Price by Application (2019-2030)
6 Key Companies Profiled
6.1 DSM
6.1.1 DSM Corporation Information
6.1.2 DSM Description and Business Overview
6.1.3 DSM Algal DHA and ARA Sales, Revenue and Gross Margin (2019-2024)
6.1.4 DSM Algal DHA and ARA Product Portfolio
6.1.5 DSM Recent Developments/Updates
6.2 Roquette
6.2.1 Roquette Corporation Information
6.2.2 Roquette Description and Business Overview
6.2.3 Roquette Algal DHA and ARA Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Roquette Algal DHA and ARA Product Portfolio
6.2.5 Roquette Recent Developments/Updates
6.3 ADM
6.3.1 ADM Corporation Information
6.3.2 ADM Description and Business Overview
6.3.3 ADM Algal DHA and ARA Sales, Revenue and Gross Margin (2019-2024)
6.3.4 ADM Algal DHA and ARA Product Portfolio
6.3.5 ADM Recent Developments/Updates
6.4 Corbion
6.4.1 Corbion Corporation Information
6.4.2 Corbion Description and Business Overview
6.4.3 Corbion Algal DHA and ARA Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Corbion Algal DHA and ARA Product Portfolio
6.4.5 Corbion Recent Developments/Updates
6.5 Lonza Group
6.5.1 Lonza Group Corporation Information
6.5.2 Lonza Group Description and Business Overview
6.5.3 Lonza Group Algal DHA and ARA Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Lonza Group Algal DHA and ARA Product Portfolio
6.5.5 Lonza Group Recent Developments/Updates
6.6 CABIO
6.6.1 CABIO Corporation Information
6.6.2 CABIO Description and Business Overview
6.6.3 CABIO Algal DHA and ARA Sales, Revenue and Gross Margin (2019-2024)
6.6.4 CABIO Algal DHA and ARA Product Portfolio
6.6.5 CABIO Recent Developments/Updates
6.7 AlgiSys
6.6.1 AlgiSys Corporation Information
6.6.2 AlgiSys Description and Business Overview
6.6.3 AlgiSys Algal DHA and ARA Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AlgiSys Algal DHA and ARA Product Portfolio
6.7.5 AlgiSys Recent Developments/Updates
6.8 Fuxing
6.8.1 Fuxing Corporation Information
6.8.2 Fuxing Description and Business Overview
6.8.3 Fuxing Algal DHA and ARA Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Fuxing Algal DHA and ARA Product Portfolio
6.8.5 Fuxing Recent Developments/Updates
6.9 Runke
6.9.1 Runke Corporation Information
6.9.2 Runke Description and Business Overview
6.9.3 Runke Algal DHA and ARA Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Runke Algal DHA and ARA Product Portfolio
6.9.5 Runke Recent Developments/Updates
6.10 Cellana
6.10.1 Cellana Corporation Information
6.10.2 Cellana Description and Business Overview
6.10.3 Cellana Algal DHA and ARA Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Cellana Algal DHA and ARA Product Portfolio
6.10.5 Cellana Recent Developments/Updates
6.11 JC Biotech
6.11.1 JC Biotech Corporation Information
6.11.2 JC Biotech Algal DHA and ARA Description and Business Overview
6.11.3 JC Biotech Algal DHA and ARA Sales, Revenue and Gross Margin (2019-2024)
6.11.4 JC Biotech Algal DHA and ARA Product Portfolio
6.11.5 JC Biotech Recent Developments/Updates
6.12 Yuexiang
6.12.1 Yuexiang Corporation Information
6.12.2 Yuexiang Algal DHA and ARA Description and Business Overview
6.12.3 Yuexiang Algal DHA and ARA Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Yuexiang Algal DHA and ARA Product Portfolio
6.12.5 Yuexiang Recent Developments/Updates
6.13 FEMICO
6.13.1 FEMICO Corporation Information
6.13.2 FEMICO Algal DHA and ARA Description and Business Overview
6.13.3 FEMICO Algal DHA and ARA Sales, Revenue and Gross Margin (2019-2024)
6.13.4 FEMICO Algal DHA and ARA Product Portfolio
6.13.5 FEMICO Recent Developments/Updates
6.14 Huison
6.14.1 Huison Corporation Information
6.14.2 Huison Algal DHA and ARA Description and Business Overview
6.14.3 Huison Algal DHA and ARA Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Huison Algal DHA and ARA Product Portfolio
6.14.5 Huison Recent Developments/Updates
6.15 Qingdao Keyuan
6.15.1 Qingdao Keyuan Corporation Information
6.15.2 Qingdao Keyuan Algal DHA and ARA Description and Business Overview
6.15.3 Qingdao Keyuan Algal DHA and ARA Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Qingdao Keyuan Algal DHA and ARA Product Portfolio
6.15.5 Qingdao Keyuan Recent Developments/Updates
6.16 Yidie
6.16.1 Yidie Corporation Information
6.16.2 Yidie Algal DHA and ARA Description and Business Overview
6.16.3 Yidie Algal DHA and ARA Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Yidie Algal DHA and ARA Product Portfolio
6.16.5 Yidie Recent Developments/Updates
6.17 Kingdomway
6.17.1 Kingdomway Corporation Information
6.17.2 Kingdomway Algal DHA and ARA Description and Business Overview
6.17.3 Kingdomway Algal DHA and ARA Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Kingdomway Algal DHA and ARA Product Portfolio
6.17.5 Kingdomway Recent Developments/Updates
6.18 Shandong Yuexiang
6.18.1 Shandong Yuexiang Corporation Information
6.18.2 Shandong Yuexiang Algal DHA and ARA Description and Business Overview
6.18.3 Shandong Yuexiang Algal DHA and ARA Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Shandong Yuexiang Algal DHA and ARA Product Portfolio
6.18.5 Shandong Yuexiang Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Algal DHA and ARA Industry Chain Analysis
7.2 Algal DHA and ARA Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Algal DHA and ARA Production Mode & Process
7.4 Algal DHA and ARA Sales and Marketing
7.4.1 Algal DHA and ARA Sales Channels
7.4.2 Algal DHA and ARA Distributors
7.5 Algal DHA and ARA Customers
8 Algal DHA and ARA Market Dynamics
8.1 Algal DHA and ARA Industry Trends
8.2 Algal DHA and ARA Market Drivers
8.3 Algal DHA and ARA Market Challenges
8.4 Algal DHA and ARA Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Food & Beverages Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
